Average Co-Inventor Count = 4.86
ph-index = 34
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Allergan, Inc. (36 from 2,285 patents)
2. Allergan Sales, Inc. (24 from 228 patents)
3. Pfizer Corporation (8 from 4,455 patents)
4. Agouron Pharmaceuticals, Inc. (8 from 174 patents)
5. Forge Therapeutics, Inc. (5 from 5 patents)
6. Other (4 from 832,680 patents)
7. Blacksmith Medicines, Inc. (3 from 3 patents)
8. Merck Sharp + Dohme Corp. (2 from 2,405 patents)
9. Novo Nordisk A/s (2 from 1,777 patents)
10. Lawrence Livermore National Security, LLC (2 from 1,571 patents)
11. Pfizer Products Inc. (2 from 47 patents)
12. Allergen Sales, Inc. (1 from 4 patents)
93 patents:
1. 12325699 - Antibacterial compounds
2. 12187754 - LpxC inhibitors and uses thereof
3. 11780853 - Substituted N-pyrimidin-4-yl-3-aminopyrrolo[3,4-C]pyrazoles as protein kinase C inhibitors
4. 11731962 - LpxC inhibitor and methods of making
5. 11407740 - Antibacterial compounds
6. 11220518 - Substituted n-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazoles as protein kinase C inhibitors
7. 11021471 - Antibacterial compounds
8. 10875832 - Substituted pyrimidines for treating bacterial infections
9. 10865216 - Tricyclic Gyrase inhibitors
10. 10611747 - Pyrone based compounds for treating bacterial infections
11. 10414735 - Substituted hydroxypyrimidinones for treating bacterial infections
12. 10385055 - Tricyclic gyrase inhibitors
13. 10316045 - Substituted pyrrolo[3,4-c]pyrazoles as pkc kinase inhibitors
14. 9518060 - Substituted pyrrolo[3,4-c]pyrazoles as PKC kinase inhibitors
15. 8999981 - [object Object]